Cyclooxygenase-2 Expression Induces Genomic Instability in MCF10A Breast Epithelial Cells

Journal of Surgical Research

Volumn 140, Issue 2, 2007, Pages 220-226

  Singh, Balraj ^a   Vincent, Laura ^a   Berry, Jacob A ^a   Multani, Asha S ^a   Lucci, Anthony ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

anoikis; breast cancer; CHK1; COX 2; genomic instability; premalignant transformation

Indexed keywords

CHECKPOINT KINASE 1; CYCLOOXYGENASE 2; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; BREAST; CELL CYCLE; CELL CYCLE ARREST; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; GENETIC TRANSFECTION; GENOMIC INSTABILITY; GIEMSA STAIN; HUMAN; HUMAN CELL; METAPHASE; MOUSE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; TETRAPLOIDY; TUMOR;

ANIMALS; ANOIKIS; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELL LINE; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DNA DAMAGE; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOMIC INSTABILITY; HUMANS; MICE; MICE, NUDE; PHENOTYPE; PRECANCEROUS CONDITIONS; PROTEIN KINASES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 34248224164     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.01.039     Document Type: Article

References (24)

1. Singh B., and Lucci A. Role of cyclooxygenase-2 in breast cancer. J Surg Res 108 (2002) 173
2. Howe L.R., and Dannenberg A.J. COX-2 inhibitors for the prevention of breast cancer. J Mammary Gland Biol Neoplasia 8 (2003) 31
3. Wang D., and DuBois R.N. Cyclooxygenase-2: A potential target in breast cancer. Semin Oncol 31 (2004) 64
4. Crawford Y.G., Gauthier M.L., Joubel A., et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 5 (2004) 263
5. Gupta G.P., and Massague J. Cancer metastasis: Building a framework. Cell 127 (2006) 679
6. Singh B., Berry J.A., Shoher A., et al. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26 (2005) 1393
7. Singh B., Berry J.A., Shoher A., et al. COX-2 induces IL-11 production in human breast cancer cells. J Surg Res 131 (2006) 267
8. Singh B., Berry J.A., Vincent L.E., et al. Involvement of IL-8 in COX-2 mediated bone metastases from breast cancer. J Surg Res 134 (2006) 44
9. Liu C.H., Chang S.-H., Narko K., et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276 (2001) 18563
10. Lin M.T., Lee R.C., Yang P.C., et al. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 276 (2001) 48997
11. Durkin S.G., Arlt M.F., Howlett N.G., et al. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25 (2006) 4381
12. Xiao Z., Xue J., Sowin T.J., et al. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: Implications for cancer therapy. Mol Cancer Ther 5 (2006) 1935
13. Lam M.H., Liu Q., Elledge S.J., et al. Chk1 is haplo-insufficient for multiple functions critical to tumor suppression. Cancer Cell 6 (2004) 45
14. Puc J., Keniry M., Li H.S., et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7 (2005) 193
15. Puc J., and Parsons R. PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells. Cell Cycle 4 (2005) 927
16. Guo Q., Wang L.H., Ruan K.H., et al. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents. J Biol Chem 271 (1996) 19134
17. Arguello F., Baggs R.B., and Frantz C.N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48 (1988) 6876
18. Singh B., Berry J.A., Shoher A., et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene (2007) Jan 8; [Epub ahead of print]
19. Chin K., DeVries S., Fridlyand J., et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10 (2006) 529
20. Neve R.M., Chin K., Fridlyand J., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515
21. Scaltriti M., and Baselga J. The epidermal growth factor receptor pathway: A model for targeted therapy. Clin Cancer Res 12 (2006) 5268
22. Choi E.M., Kwak S.J., Kim Y.M., et al. COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Exp Mol Med 37 (2005) 199
23. Shekhar P.V., Chen M.L., Werdell J., et al. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: A model for early breast cancer. Int J Oncol 13 (1998) 907
24. Lu S., Yu G., Zhu Y., et al. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis, and differentiation, and causes partial transformation. Int J Cancer 116 (2005) 847